Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 428 of 6351
-
Promising new combo targets tough lymphoma in older adults
Disease control Recruiting nowThis single-arm, interventional phase 2 study is designed to evaluate whether the inclusion of mosunetuzumab subcutaneous and polatuzumab vedotin (Mosun-Pola) to a split-dose CHP chemotherapy backbone will improve outcomes for elderly patients with a new diagnosis of diffuse larg…
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New heart pump could be lifeline for failing hearts
Disease control Recruiting nowThis clinical investigation evaluates the safety and clinical performance of the BrioVAD Left Ventricular Assist System in patients with advanced, refractory left ventricular heart failure who require mechanical circulatory support.
Sponsor: BrioHealth BV • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells take on hard-to-treat breast cancer in new trial
Disease control Not yet recruitingThe purpose of this study is to find the biggest dose of HTR2 T cells that is safe, to see how long these cells last in the body, to learn the side effects, and to see if these cells are able to fight and kill HER2 expressing breast cancer. Patients eligible for this study have …
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can CBD boost clozapine for Treatment-Resistant psychosis?
Disease control Not yet recruitingThe purpose of this trial is: * To investigate whether the response to clozapine treatment can be enhanced by adding cannabidiol (CBD), compared to placebo, in treatment resistant psychosis patients. * To confirm the safety of CBD in people with psychosis. The trial is a random…
Phase 3 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Vitamin d trial aims to protect pregnant women from Life-Threatening conditions
Prevention Not yet recruitingThe goal of this randomised controlled trial is to investigate if vitamin D supplementation among pregnant women in Uganda prevents adverse maternal and foetal outcomes, with special emphasis on preeclampsia. The main question it aims to answer is if Vitamin D supplementation, a…
Phase 4 • Sponsor: St Mary's Hospital, Lacor • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Could stem cells save limbs? new trial tests healing power for leg ulcers
Disease control Not yet recruitingPeripheral arterial disease (PAD) can progress to critical limb ischemia (CLI) of the affected lower limb, characterized by pain at rest, ulcerations or gangrene, with a high risk of amputation. In this phase, the best treatment is arterial limb revascularization, but this is not…
Phase 1/2 • Sponsor: UPECLIN HC FM Botucatu Unesp • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New quadruple therapy targets liver cancer and diabetes together
Disease control Not yet recruitingThe purpose of this study is to evaluate the comprehensive therapeutic efficacy and safety profile of the epalrestat combined with hepatic artery infusion chemotherapy (HAIC), donafenib and tislelizumab quadruple regimen in patients with unresectable hepatocellular carcinoma (HCC…
Phase 2 • Sponsor: Haibo Shao • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New model may predict and prevent deadly transplant complication
Disease control Not yet recruitingThis study aims to evaluate the efficacy of prophylactic ruxolitinib in adult patients at intermediate-to-high risk of severe acute GvHD, as predicted by the daGOAT model.
Phase 3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail aims to shrink kidney tumors before surgery
Disease control Not yet recruitingThis study is designed to evaluate the efficacy of belzutifan in combination with pembrolizumab with or without lenvatinib in the neoadjuvant setting, followed by adjuvant pembrolizumab versus adjuvant pembrolizumab alone, as treatment for participants with intermediate-high and …
Phase 2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a diabetes shot help beat uterine cancer without surgery?
Disease control Not yet recruitingThis study is looking for a better way to treat pre-cancer or early-stage cancer in the lining of the uterus in women who are also overweight. Everyone in the study will receive the standard treatment, a Progesterone IUD (LNG-IUD). This device is put in the uterus and releases h…
Phase 2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo targets tough lymphoma subtypes in early trial
Disease control Recruiting nowThis is a prospective, open-label, single-arm, single-center, Phase II clinical study designed to evaluate the efficacy and safety of Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients …
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Genetic test may guide chemo choice for pancreatic cancer patients
Disease control Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) exhibits significant heterogeneity, making the optimal choice of chemotherapy challenging. While targeted therapies benefit from companion biomarkers, few tools exist to guide the selection of cytotoxic chemotherapy. Transcriptomic signatur…
Phase 2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New 'Off-the-Shelf' CAR-T therapy takes on Hard-to-Treat myeloma
Disease control Not yet recruitingThis is a prospective, single-arm, open-label, early exploratory clinical study designed to evaluate the safety, tolerability, and efficacy of the DQ1001 cell product in patients with relapsed or refractory multiple myeloma. All participants will receive intravenous infusions of …
Phase 1 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a nasal spray after childbirth ward off postpartum depression?
Disease control Not yet recruitingEsketamine has rapid-onset antidepressant effects and may reduce postpartum depression in parturients with prenatal depressive symptoms. However, its adverse neuropsychiatric symptoms limits clinical application. Dexmedetomidine can alleviate these adverse symptoms and has indepe…
Phase 4 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo aims to fix transfusion failure in blood cancer patients
Disease control Not yet recruitingPlatelet transfusion refractoriness (PTR) is a common complication in patients with hematological malignancies. It not only prolongs the duration of platelet transfusion dependence and significantly increases the risk of bleeding, but is also strongly associated with graft failur…
Phase 3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Smart breathing device aims to speed lung recovery after cancer surgery
Disease control Not yet recruitingThis study will compare an intelligent pulmonary function exercise device with usual care and natural recovery in patients recovering from lung cancer surgery. After lung cancer surgery, many patients have reduced lung function, shortness of breath, lower exercise tolerance, and…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Engineered immune cells take aim at two cancer targets
Disease control Stopped earlyThe purpose of this study is to assess the feasibility, safety and efficacy of anti-PSMA/CD70 bi-specific CAR-T cell therapy in patients with CD70 and PSMA positive malignancies. Another goal of the study is to learn more about the function of the PSMA/CD70 bi-specific CAR-T cell…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Glowing dye could reveal invisible cancer clues in the esophagus
Diagnosis Not yet recruitingThe goal of this clinical trial is to evaluate the feasibility of WGA-800CW with dedicated imaging systems for detection of invisible esophageal dysplasia in patients with Barrett's esophagus. The main questions it aims to answer are: * What is the optimal dose of WGA-800CW tha…
Phase 1 • Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingCholestatic liver diseases are characterized by jaundice, pruritus, and elevated levels of alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT). Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) represent the major autoimmune-driven entities wi…
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
A second look: MRI screening may spot hidden prostate cancers
Prevention Recruiting nowProstate cancer remains one of the leading causes of cancer-related morbidity and mortality among men. While PSA-based screening has been associated with reduced prostate cancer mortality, it also results in substantial overdiagnosis and overtreatment of clinically insignificant …
Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC